Related Experiment Video
Updated: Feb 28, 2026

Fully Processed Recombinant KRAS4b: Isolating and Characterizing the Farnesylated and Methylated Protein
Published on: January 16, 2020
The G protein-coupled receptor GPR31 promotes membrane association of KRAS
Nicole Fehrenbacher1, Israel Tojal da Silva2, Craig Ramirez3
1Perlmutter Cancer Center, New York University School of Medicine, New York, NY nfehren01@gmail.com.
Abstract:
The product of the KRAS oncogene, KRAS4B, promotes tumor growth when associated with the plasma membrane (PM). PM association is mediated, in part, by farnesylation of KRAS4B, but trafficking of nascent KRAS4B to the PM is incompletely understood. We performed a genome-wide screen to identify genes required for KRAS4B membrane association and identified a G protein-coupled receptor, GPR31. GPR31 associated with KRAS4B on cellular membranes in a farnesylation-dependent fashion, and retention of GPR31 on the endoplasmic reticulum inhibited delivery of KRAS4B to the PM. Silencing of GPR31 expression partially mislocalized KRAS4B, slowed the growth of KRAS-dependent tumor cells, and blocked KRAS-stimulated macropinocytosis. Our data suggest that GPR31 acts as a secretory pathway chaperone for KRAS4B.
Insights
G protein-coupled receptor 31 (GPR31) acts as a chaperone, escorting the KRAS4B protein to the plasma membrane. This interaction is crucial for KRAS4B
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- KRAS4B protein is a key driver of tumor growth, requiring plasma membrane association.
- The precise mechanisms governing KRAS4B trafficking to the plasma membrane remain unclear.
Purpose of the Study:
- To identify genes essential for KRAS4B plasma membrane association.
- To elucidate the role of GPR31 in KRAS4B trafficking and function.
Main Methods:
- Genome-wide genetic screen to identify novel interacting genes.
- Cellular localization studies using microscopy.
- Gene silencing experiments to assess functional impact.
Main Results:
- G protein-coupled receptor 31 (GPR31) was identified as a novel binding partner for KRAS4B.
- GPR31 mediates KRAS4B plasma membrane association in a farnesylation-dependent manner.
- GPR31 silencing impairs KRAS4B trafficking, slows tumor cell growth, and inhibits macropinocytosis.
Conclusions:
- GPR31 functions as a secretory pathway chaperone for KRAS4B.
- Targeting GPR31 may offer a therapeutic strategy for KRAS-driven cancers.
Related Concept Videos
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
The Ras Gene
Ras is a...
G Protein-coupled Receptors
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
G-protein Coupled Receptors
Rab Proteins
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
Transducer Mechanism: G Protein–Coupled Receptors
GPCRs are also called heptahelical,...

